Francesco Panzuto | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Surgery with Radical Intent. Is There an Indication for G3 Neuroendocrine Neoplasms?	ANNALS OF SURGICAL ONCOLOGY	2020
Perioperative chemotherapy in poorly differentiated neuroendocrine neoplasia of the bladder. A multicenter analysis	JOURNAL OF CLINICAL MEDICINE	2020
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm. Study Protocol for a Prospective Observational Study	FRONTIERS IN MEDICINE	2020
Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center	JOURNAL OF CLINICAL MEDICINE	2019
Role of combined [68Ga]Ga-DOTA-SST analogues and [18F]FDG PET/CT in the management of GEP-NENs: a systematic review	JOURNAL OF CLINICAL MEDICINE	2019
Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: a multicentre retrospective study	DIGESTIVE AND LIVER DISEASE	2019
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: a comparison between pancreatic and gastrointestinal localizations	PANCREATOLOGY	2019
The ENETS TNM staging and grading system accurately predict prognosis in patients with rectal NENs	DIGESTIVE AND LIVER DISEASE	2019
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms. Data from a large international cohort study	NEUROENDOCRINOLOGY	2019
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: a real-world study	PANCREATOLOGY	2018
Heterogeneity of duodenal neuroendocrine tumors: an Italian multi-center experience	ANNALS OF SURGICAL ONCOLOGY	2018
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues	GASTROENTEROLOGY	2018
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors	ENDOCRINE-RELATED CANCER	2018
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms	THE ONCOLOGIST	2018
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study	HPB	2018
Therapy for Locoregional Disease. Stomach/Duodenum, Colon/Rectum	Neuroendocrine Tumors in Real Life	2018
Evaluation of the relationships between computed tomography features, pathological findings, and rrognostic risk assessment in gastrointestinal stromal tumors	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY	2017
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms	PLOS ONE	2017
Functional imaging in the follow-up of enteropancreatic neuroendocrine tumors: Clinical usefulness and indications	THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM	2017
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY	2017